{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:36:40Z","timestamp":1762497400994,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T00:00:00Z","timestamp":1610323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.aace.2021.01.003","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T01:11:33Z","timestamp":1611018693000},"page":"200-203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma"],"prefix":"10.1016","volume":"7","author":[{"given":"Jeffrey M.","family":"Kroopnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubaldo","family":"Martinez-Outschoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina","family":"Tuluc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aace.2021.01.003_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202861","article-title":"Denosumab may be the treatment of choice for bisphosphonate refractory hypercalcemia of malignancy","volume":"2014","author":"Adhikaree","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.aace.2021.01.003_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/IJGM.S51302","article-title":"An unusual case of malignancy-related hypercalcemia","volume":"7","author":"Doyle","year":"2013","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.aace.2021.01.003_bib3","first-page":"17","article-title":"Hypercalcemia of malignancy treated with cinacalcet","author":"Asonitis","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"10.1016\/j.aace.2021.01.003_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1507\/endocrj.EJ12-0406","article-title":"Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature","volume":"60","author":"Nakajima","year":"2013","journal-title":"Endocr J"},{"issue":"7","key":"10.1016\/j.aace.2021.01.003_bib5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/meta.2002.33341","article-title":"Lung cancer associated with hypercalcemia induced by concurrently elevated parathyroid hormone and parathyroid hormone-related protein levels","volume":"51","author":"Uchimura","year":"2002","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.aace.2021.01.003_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4158\/EP.10.2.125","article-title":"Recurrent hypercalcemia due to ectopic production of parathyroid hormone-related protein and intact parathyroid hormone in a single patient with multiple malignancies","volume":"10","author":"Eid","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1016\/j.aace.2021.01.003_bib7","first-page":"469","article-title":"Hyperparathyroidism secondary to zoledronic acid infusion: case report","volume":"17","author":"Sayn","year":"2009","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.aace.2021.01.003_bib8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JOP.2016.011155","article-title":"Cancer-related hypercalcemia","volume":"12","author":"Goldner","year":"2016","journal-title":"J\u00a0Oncol Pract"},{"issue":"4","key":"10.1016\/j.aace.2021.01.003_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJMcp042806","article-title":"Hypercalcemia associated with cancer","volume":"352","author":"Stewart","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.aace.2021.01.003_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1053\/j.ajkd.2013.06.025","article-title":"Approach to the diagnosis and treatment of hypercalcemia in a patient with malignancy","volume":"63","author":"Reagan","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"10.1016\/j.aace.2021.01.003_bib11","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2217\/fon.15.232","article-title":"Denosumab: a new agent in the management of hypercalcemia of malignancy","volume":"11","author":"Thosani","year":"2015","journal-title":"Future Oncol"},{"issue":"9","key":"10.1016\/j.aace.2021.01.003_bib12","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2014-1001","article-title":"Denosumab for the treatment of hypercalcemia of malignancy","volume":"99","author":"Hu","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.aace.2021.01.003_bib13","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/j.clml.2015.06.007","article-title":"PTHrP-induced refractory malignant hypercalcemia in a patient with chronic lymphocytic leukemia responding to denosumab","volume":"15","author":"Salahudeen","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"10.1016\/j.aace.2021.01.003_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ccr3.2631","article-title":"A\u00a0rare case of hypercalcemic encephalopathy from ectopic secretion of parathyroid hormone","volume":"8","author":"Gabriel","year":"2020","journal-title":"Clin Case Rep"},{"issue":"12","key":"10.1016\/j.aace.2021.01.003_bib15","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/SMJ.0b013e318181d59d","article-title":"Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell endometrial cancer","volume":"101","author":"Richey","year":"2008","journal-title":"South Med J"},{"issue":"1","key":"10.1016\/j.aace.2021.01.003_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1590\/2359-3997000000015","article-title":"Association of primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with clear cell renal carcinoma","volume":"59","author":"Gomes","year":"2015","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.aace.2021.01.003_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5306\/wjco.v3.i1.7","article-title":"Challenges in the differential diagnosis of hypercalcemia: a case of hypercalcemia with normal PTH level","volume":"3","author":"Pellicciotti","year":"2012","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.aace.2021.01.003_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/0140-6736(92)90220-W","article-title":"Role of assays of parathyroid-hormone-related protein in investigation of hypercalcemia","volume":"339","author":"Ratcliffe","year":"1992","journal-title":"Lancet"},{"issue":"pt 2","key":"10.1016\/j.aace.2021.01.003_bib19","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/000456329102800207","article-title":"A\u00a0two-site immunoradiometric assay for PTH (1-84) using N and C terminal specific monoclonal antibodies","volume":"28","author":"Logue","year":"1991","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.aace.2021.01.003_bib20","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4065\/77.8.866","article-title":"Concurrent parathyroid adenomas and carcinoma in the setting of multiple endocrine neoplasia type 1: presentation as hypercalcemic crisis","volume":"77","author":"Dionisi","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.aace.2021.01.003_bib21","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1046\/j.1523-1755.1998.00142.x","article-title":"Persistent secondary hyperparathyroidism after renal transplantation","volume":"54","author":"Messa","year":"1998","journal-title":"Kidney Int"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060521000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2376060521000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:54Z","timestamp":1762497114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2376060521000122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2376060521000122"],"URL":"https:\/\/doi.org\/10.1016\/j.aace.2021.01.003","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercalcemia of Malignancy Attributed to Cosecretion of PTH and PTHRP in Lung Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aace.2021.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}